US Patent 11802155 ILT-binding agents and methods of use thereof
Patent 11802155 was granted and assigned to NGM Biopharmaceuticals on October, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 1 Nov, 2023
Golden AI
Edits made to:
Infobox (+31 properties)
Article (+355 characters)
US Patent 11802155 ILT-binding agents and methods of use thereof
Article
Patent abstract
The present disclosure provides binding agents, such as antibodies, that specifically bind ILT2, ILT4, or both ILT2 and ILT4, as well as compositions comprising the binding agents, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising the binding agents.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Allen James Ebens, Jr.
Chia-Ying Kao Lam
Dana Yen Mei Duey
Daniel David Kaplan
Geoffrey William Stone
Kalyani Mondal
Yan Wang
Date of Patent
October 31, 2023
Patent Application Number
17244169
Date Filed
April 29, 2021
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11802155 ILT-binding agents and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
